TY - JOUR
T1 - 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes
T2 - A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
AU - Rao, Sunil V.
AU - O'Donoghue, Michelle L.
AU - Ruel, Marc
AU - Rab, Tanveer
AU - Tamis-Holland, Jaqueline E.
AU - Alexander, John H.
AU - Baber, Usman
AU - Baker, Heather
AU - Cohen, Mauricio G.
AU - Cruz-Ruiz, Mercedes
AU - Davis, Leslie L.
AU - de Lemos, James A.
AU - DeWald, Tracy A.
AU - Elgendy, Islam Y.
AU - Feldman, Dmitriy N.
AU - Goyal, Abhinav
AU - Isiadinso, Ijeoma
AU - Menon, Venu
AU - Morrow, David A.
AU - Mukherjee, Debabrata
AU - Platz, Elke
AU - Promes, Susan B.
AU - Sandner, Sigrid
AU - Sandoval, Yader
AU - Schunder, Rachel
AU - Shah, Binita
AU - Stopyra, Jason P.
AU - Talbot, Amy W.
AU - Taub, Pam R.
AU - Williams, Marlene S.
AU - Jneid, Hani
AU - Beavers, Craig J.
AU - Beckie, Theresa
AU - Blankenship, Jim
AU - Diercks, Deborah
AU - Lo, Bruce
AU - Louis, Clauden
AU - Merchant, Faisal M.
AU - Nazir, Noreen T.
AU - So, Derek
AU - Tomey, Matthew
AU - Welt, Frederick
N1 - Publisher Copyright:
© 2025 American College of Cardiology Foundation, and the American Heart Association, Inc.
PY - 2025/6/10
Y1 - 2025/6/10
N2 - Aim: The “2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes” incorporates new evidence since the “2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction” and the corresponding “2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes” and the “2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction.” The “2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes” and the “2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization” retire and replace, respectively, the “2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease.” Methods: A comprehensive literature search was conducted from July 2023 to April 2024. Clinical studies, systematic reviews and meta-analyses, and other evidence conducted on human participants were identified that were published in English from MEDLINE (through PubMed), EMBASE, the Cochrane Library, Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. Structure: Many recommendations from previously published guidelines have been updated with new evidence, and new recommendations have been created when supported by published data.
AB - Aim: The “2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes” incorporates new evidence since the “2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction” and the corresponding “2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes” and the “2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction.” The “2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes” and the “2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization” retire and replace, respectively, the “2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease.” Methods: A comprehensive literature search was conducted from July 2023 to April 2024. Clinical studies, systematic reviews and meta-analyses, and other evidence conducted on human participants were identified that were published in English from MEDLINE (through PubMed), EMBASE, the Cochrane Library, Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. Structure: Many recommendations from previously published guidelines have been updated with new evidence, and new recommendations have been created when supported by published data.
KW - ACC/AHA clinical practice guideline
KW - EMS
KW - ST-segment elevation myocardial infarction
KW - acute coronary syndrome(s)
KW - angina
KW - anticoagulants
KW - aspirin
KW - atrial fibrillation
KW - cardiovascular diseases
KW - coronary artery disease
KW - coronary syndrome
KW - emergency medical services
KW - fibrinolytic agents
KW - hemorrhage
KW - major adverse cardiovascular events
KW - morphine
KW - myocardial infarction
KW - non–ST-segment elevation myocardial infarction
KW - percutaneous coronary intervention
KW - prehospital
KW - revascularization
KW - risk
KW - time factors
KW - treatment outcome
KW - unstable
UR - https://www.scopus.com/pages/publications/105000711208
UR - https://www.scopus.com/pages/publications/105000711208#tab=citedBy
U2 - 10.1016/j.jacc.2024.11.009
DO - 10.1016/j.jacc.2024.11.009
M3 - Article
C2 - 40013746
AN - SCOPUS:105000711208
SN - 0735-1097
VL - 85
SP - 2135
EP - 2237
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 22
ER -
Good health and well being